BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31873861)

  • 21. Epidemiology of Methicillin-Resistant
    Hamdy RF; Hsu AJ; Stockmann C; Olson JA; Bryan M; Hersh AL; Tamma PD; Gerber JS
    Pediatrics; 2017 Jun; 139(6):. PubMed ID: 28562284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methicillin-resistant Staphylococcus aureus (MRSA) staphylococcal cassette chromosome mec genotype effects outcomes of patients with healthcare-associated MRSA bacteremia independently of vancomycin minimum inhibitory concentration.
    Chen SY; Liao CH; Wang JL; Chiang WC; Lai MS; Chie WC; Chen WJ; Chang SC; Hsueh PR
    Clin Infect Dis; 2012 Nov; 55(10):1329-37. PubMed ID: 22911641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. agr Dysfunction and persistent methicillin-resistant Staphylococcus aureus bacteremia in patients with removed eradicable foci.
    Park SY; Chong YP; Park HJ; Park KH; Moon SM; Jeong JY; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS
    Infection; 2013 Feb; 41(1):111-9. PubMed ID: 23065454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. agr dysfunction affects staphylococcal cassette chromosome mec type-dependent clinical outcomes in methicillin-resistant Staphylococcus aureus bacteremia.
    Kang CK; Cho JE; Choi YJ; Jung Y; Kim NH; Kim CJ; Kim TS; Song KH; Choe PG; Park WB; Bang JH; Kim ES; Park KU; Park SW; Kim NJ; Oh MD; Kim HB
    Antimicrob Agents Chemother; 2015; 59(6):3125-32. PubMed ID: 25779574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Outcomes among Adult Patients with Nosocomial Bacteremia Caused by Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus: A Retrospective Cohort Study.
    Wang JT; Hsu LY; Lauderdale TL; Fan WC; Wang FD
    PLoS One; 2015; 10(12):e0144710. PubMed ID: 26690351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of antimicrobial regimen on decreased in-hospital mortality of patients with MRSA bacteremia.
    Kaku N; Yanagihara K; Morinaga Y; Yamada K; Harada Y; Migiyama Y; Nagaoka K; Matsuda J; Uno N; Hasegawa H; Miyazaki T; Izumikawa K; Kakeya H; Yamamoto Y; Kohno S
    J Infect Chemother; 2014 Jun; 20(6):350-5. PubMed ID: 24731430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations - results of a prematurely terminated study.
    Kalimuddin S; Chan YFZ; Phillips R; Ong SP; Archuleta S; Lye DC; Tan TT; Low JGH
    Trials; 2018 Jun; 19(1):305. PubMed ID: 29859132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: a retrospective case series of 10 patients.
    Lin JC; Aung G; Thomas A; Jahng M; Johns S; Fierer J
    J Infect Chemother; 2013 Feb; 19(1):42-9. PubMed ID: 22797874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Community-Onset Methicillin-Resistant
    Bae E; Kim CK; Jang JH; Sung H; Choi Y; Kim MN
    Ann Lab Med; 2019 Mar; 39(2):158-166. PubMed ID: 30430778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.
    Tong SYC; Lye DC; Yahav D; Sud A; Robinson JO; Nelson J; Archuleta S; Roberts MA; Cass A; Paterson DL; Foo H; Paul M; Guy SD; Tramontana AR; Walls GB; McBride S; Bak N; Ghosh N; Rogers BA; Ralph AP; Davies J; Ferguson PE; Dotel R; McKew GL; Gray TJ; Holmes NE; Smith S; Warner MS; Kalimuddin S; Young BE; Runnegar N; Andresen DN; Anagnostou NA; Johnson SA; Chatfield MD; Cheng AC; Fowler VG; Howden BP; Meagher N; Price DJ; van Hal SJ; O'Sullivan MVN; Davis JS;
    JAMA; 2020 Feb; 323(6):527-537. PubMed ID: 32044943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characteristics and therapeutic outcomes of hematogenous vertebral osteomyelitis caused by methicillin-resistant Staphylococcus aureus.
    Park KH; Chong YP; Kim SH; Lee SO; Choi SH; Lee MS; Jeong JY; Woo JH; Kim YS
    J Infect; 2013 Dec; 67(6):556-64. PubMed ID: 23916563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Staphylococcal enterotoxin P predicts bacteremia in hospitalized patients colonized with methicillin-resistant Staphylococcus aureus.
    Calderwood MS; Desjardins CA; Sakoulas G; Nicol R; Dubois A; Delaney ML; Kleinman K; Cosimi LA; Feldgarden M; Onderdonk AB; Birren BW; Platt R; Huang SS;
    J Infect Dis; 2014 Feb; 209(4):571-7. PubMed ID: 24041793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: Correlations between clinical, phenotypic, genotypic characteristics and mortality in a tertiary teaching hospital in Malaysia.
    Sit PS; Teh CSJ; Idris N; Ponnampalavanar S
    Infect Genet Evol; 2018 Apr; 59():132-141. PubMed ID: 29421224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan.
    Lin SH; Liao WH; Lai CC; Liao CH; Tan CK; Wang CY; Huang YT; Hsueh PR
    J Antimicrob Chemother; 2010 Aug; 65(8):1792-8. PubMed ID: 20511366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.
    Arshad S; Huang V; Hartman P; Perri MB; Moreno D; Zervos MJ
    Int J Infect Dis; 2017 Apr; 57():27-31. PubMed ID: 28131729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences between "classical" risk factors for infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and risk factors for nosocomial bloodstream infections caused by multiple clones of the staphylococcal cassette chromosome mec type IV MRSA strain.
    Vidal PM; Trindade PA; Garcia TO; Pacheco RL; Costa SF; Reinert C; Hiramatsu K; Mamizuka EM; Garcia CP; Levin AS
    Infect Control Hosp Epidemiol; 2009 Feb; 30(2):139-45. PubMed ID: 19146463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Dysregulated Balance of Proinflammatory and Anti-Inflammatory Host Cytokine Response Early During Therapy Predicts Persistence and Mortality in Staphylococcus aureus Bacteremia.
    Minejima E; Bensman J; She RC; Mack WJ; Tuan Tran M; Ny P; Lou M; Yamaki J; Nieberg P; Ho J; Wong-Beringer A
    Crit Care Med; 2016 Apr; 44(4):671-9. PubMed ID: 26540400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study.
    Yaw LK; Robinson JO; Ho KM
    Lancet Infect Dis; 2014 Oct; 14(10):967-75. PubMed ID: 25185461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia.
    Melzer M; Eykyn SJ; Gransden WR; Chinn S
    Clin Infect Dis; 2003 Dec; 37(11):1453-60. PubMed ID: 14614667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time trends in Staphylococcus aureus bacteremia, 1988-2010, in a tertiary center with high methicillin resistance rates.
    Yahav D; Shaked H; Goldberg E; Yassin S; Eliakim-Raz N; Paul M; Bishara J; Leibovici L
    Infection; 2017 Feb; 45(1):51-57. PubMed ID: 27411532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.